share_log

Cantor Fitzgerald Downgrades IBio to Neutral, Lowers Price Target to $0.17

Benzinga Real-time News ·  Oct 7, 2022 05:21

Cantor Fitzgerald analyst Kristen Kluska downgrades iBio (AMEX:IBIO) from Overweight to Neutral and lowers the price target from $2.5 to $0.17.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment